Found 60 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
"InDACtion" vs "3+7" Induction in AML PHASE3 Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chan...
Show More Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS PHASE2 This study was designed as a prospective, multicenter, open-label, randomiz...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia PHASE2 Primary Outcome Measures:
• To evaluate the efficacy of treatment with Aza...
Show More Location
Hospital Reina Sofía, Servicio de Hematología
Learn More & Join Trial
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment PHASE2 This is a prospective, open-label, randomized, cross-over, pilot study of r...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine PHASE2 This is a randomized phase II, four-arm, open-label, multi-center study in ...
Show More Location
Universitätsklinikum Innsbruck
Learn More & Join Trial
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT PHASE2 Allo-HSCT is the most effective way to cure sAML patients. At present, the ...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial